OTCMKTS:ACAR - Activecare Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$0.50
Today's Range$0.50 - $0.50
52-Week Range$0.50 - $7.81
Volume1 shs
Average Volume750 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
ActiveCare, Inc. provides chronic illness monitoring products and services in the United States and internationally. It develops, distributes, and markets biometric monitoring devices to insurance companies, disease management companies, third-party administrators, and self-insured companies for use in the mobile monitoring of patient vital signs and physical activity. The company was formerly known as Volu-Sol Reagents Corporation and changed its name to ActiveCare, Inc. in July 2009. ActiveCare, Inc. was founded in 1998 and is headquartered in Orem, Utah.

Receive ACAR News and Ratings via Email

Sign-up to receive the latest news and ratings for ACAR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ACAR
CUSIPN/A
Phone+1-801-9749474

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Activecare (OTCMKTS:ACAR) Frequently Asked Questions

What is Activecare's stock symbol?

Activecare trades on the OTCMKTS under the ticker symbol "ACAR."

Has Activecare been receiving favorable news coverage?

Media headlines about ACAR stock have trended negative on Friday, InfoTrie Sentiment reports. The research group scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Activecare earned a media sentiment score of -2.2 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the next several days.

Who are some of Activecare's key competitors?

What other stocks do shareholders of Activecare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Activecare investors own include Micron Technology (MU), Lendlease Group (LLC), Velocity Data (VCT), Arca Biopharma (ABIO), Apollo Investment (AINV), Advanced Micro Devices (AMD), Aware (AWRE), Bridgeline Digital (BLIN), Caladrius Biosciences (CLBS) and Control4 (CTRL).

Who are Activecare's key executives?

Activecare's management team includes the folowing people:
  • Mr. Jeffrey S. Peterson, Exec. VP & Director (Age 40)
  • Mr. James J. Dalton, Consultant (Age 74)
  • Mr. Mark J. Rosenblum, Chairman & CEO (Age 65)
  • Mr. Marc C. Bratsman, Part-Time Consultant (Age 40)

How do I buy shares of Activecare?

Shares of ACAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Activecare's official website?

The official website for Activecare is http://activecare.com/.

How can I contact Activecare?

Activecare's mailing address is 1365 West Business Park Drive, Suite 100, OREM, UT 84058, United States. The company can be reached via phone at +1-801-9749474.


MarketBeat Community Rating for Activecare (OTCMKTS ACAR)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  31 (Vote Outperform)
Underperform Votes:  30 (Vote Underperform)
Total Votes:  61
MarketBeat's community ratings are surveys of what our community members think about Activecare and other stocks. Vote "Outperform" if you believe ACAR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ACAR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/26/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel